Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy

被引：0
|
作者：
Paola Paci
Rossella Carello
Massimo Bernaschi
Gianpiero D'Offizi
Filippo Castiglione
机构：
[1] National Research Council,Institute for Computing Applications "Mauro Picone"
[2] I.R.C.C.S.,National Institute for Infectious Diseases "Lazzaro Spallanzani"
[3] San Pietro Hospital,Research Center
[4] Fatebenefratelli,undefined
[5] AFaR,undefined
来源：
BMC Infectious Diseases | / 9卷
关键词：
Human Immunodeficiency Virus; Viral Rebound; Plasma Viremia; Public Health Expenditure; Nucleic Acid Sequence Base Amplification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
    Paci, Paola
    Carello, Rossella
    Bernaschi, Massimo
    D'Offizi, Gianpiero
    Castiglione, Filippo
    BMC INFECTIOUS DISEASES, 2009, 9 : 172
  • [2] A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
    Ananworanich J.
    Kosalaraksa P.
    Siangphoe U.
    Engchanil C.
    Pancharoen C.
    Lumbiganon P.
    Intasan J.
    Apateerapong W.
    Chuenyam T.
    Ubolyam S.
    Bunupuradah T.
    Lange J.
    Cooper D.A.
    Phanuphak P.
    AIDS Research and Therapy, 5 (1)
  • [3] Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: Risk without reward
    Abbas, UL
    Mellors, JW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13377 - 13378
  • [4] Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection
    Lifson, Alan R.
    Grund, Birgit
    Gardner, Edward M.
    Kaplan, Richard
    Denning, Eileen
    Engen, Nicole
    Carey, Catherine L.
    Chen, Fabian
    Dao, Sounkalo
    Florence, Eric
    Sanz, Jesus
    Emery, Sean
    AIDS, 2017, 31 (07) : 953 - 963
  • [5] Early versus Deferred Antiretroviral Therapy for HIV
    Buchbinder, Susan P.
    Jain, Vivek
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 822 - 822
  • [6] Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection
    Baker, Jason V.
    Neuhaus, Jacqueline
    Duprez, Daniel
    Kuller, Lewis H.
    Tracy, Russell
    Belloso, Waldo H.
    De Wit, Stephane
    Drummond, Fraser
    Lane, H. Clifford
    Ledergerber, Bruno
    Lundgren, Jens
    Nixon, Daniel E.
    Paton, Nicholas I.
    Neaton, James D.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (01) : 36 - 43
  • [7] Prevention of HIV-1 Infection with Antiretroviral Therapy
    Rodger, Alison
    Phillips, Andrew
    Lundgren, Jens
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20): : 1934 - 1934
  • [8] ANTIRETROVIRAL COMBINATION THERAPY FOR HIV-1 INFECTION
    HERIDA, M
    PRESSE MEDICALE, 1995, 24 (23): : 1056 - 1058
  • [9] A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
    Kroon, Eugene D. M. D.
    Ananworanich, Jintanat
    Pagliuzza, Amelie
    Rhodes, Ajantha
    Phanuphak, Nittaya
    Trautmann, Lydie
    Mitchell, Julie L.
    Chintanaphol, Michelle
    Intasan, Jintana
    Pinyakorn, Suteeraporn
    Benjapornpong, Khuntalee
    Chang, J. Judy
    Colby, Donn J.
    Chomchey, Nitiya
    Fletcher, James L. K.
    Eubanks, Keith
    Yang, Hua
    Kapson, John
    Dantanarayana, Ashanti
    Tennakoon, Surekha
    Gorelick, Robert J.
    Maldarelli, Frank
    Robb, Merlin L.
    Kim, Jerome H.
    Spudich, Serena
    Chomont, Nicolas
    Phanuphak, Praphan
    Lewin, Sharon R.
    de Souza, Mark S.
    JOURNAL OF VIRUS ERADICATION, 2020, 6 (03)
  • [10] Beyond antiretroviral therapy: early interventions to control HIV-1 infection
    Gunst, Jesper D.
    Tolstrup, Martin
    Sogaard, Ole S.
    AIDS, 2017, 31 (12) : 1665 - 1667
12345